Ultrasound catheter, and mapping and ablation integrated ultrasound treatment apparatus

By designing an ultrasonic catheter with integrated mapping and ablation functions in nerve ablation technology, using ultrasonic waves and physiological signal detection, the accurate treatment of visceral nerves is achieved, the blind problems in the existing technology are solved, and the accuracy of treatment is improved. Security.

WO2024244254A1PCT designated stage expired Publication Date: 2024-12-05CHONGQING MEDICAL UNIVERSITY
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2023/123984
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-06-01
Filing Date
2023-10-11
Publication Date
2024-12-05

AI Technical Summary

Technical Problem

The lack of clear ablation targets in existing nerve ablation techniques leads to blindness in the treatment, especially in transcatheter de-renal sympathetic ablation, where it is impossible to accurately determine the immediate effect of ablation and whether the treatment goals are achieved.

Method used

Design an ultrasonic catheter that integrates mapping and ablation functions. Through ultrasonic generators, pulse ultrasonic waves are generated in mapping mode and continuous ultrasonic waves are generated in ablation mode. Combined with physiological signal detection equipment, accurate mapping and ablation of visceral nerves can be achieved. , ensure the selectivity and accuracy of treatment.

Benefits of technology

Accurate targeted treatment of visceral nerves, solving the blindness problem, and independently control the multiple ultrasound transducers of the ultrasound catheter and the balloon coolant circulation, improving the accuracy and safety of the treatment and ensuring ablation Effects and blood vessel protection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2023123984_05122024_PF_FP_ABST
    Figure CN2023123984_05122024_PF_FP_ABST
Patent Text Reader

Abstract

An ultrasound catheter, and a mapping and ablation integrated ultrasound treatment apparatus. The ultrasound catheter specifically has a catheter body, wherein at least one ultrasonic wave generation piece is provided on a catheter wall of the catheter body, a cable is provided in a hollow cavity of the catheter body, one end of the cable is connected to the ultrasonic wave generation piece, and the other end of the cable extends out of a first end of the catheter body and is connected to a cable interface. The ultrasonic wave generation piece comprises a mapping mode and an ablation mode, wherein first ultrasonic waves are generated in the mapping mode, and second ultrasonic waves are generated in the ablation mode. The integration of mapping and ablation can be realized by means of switching an operating mode of an ultrasonic wave generation piece, and by using the same ultrasonic generation piece to perform mapping and ablation, an accurate targeted treatment can be implemented, thereby solving the problem of blindness in ablation in current nerve ablation treatment; and by means of providing a plurality of ultrasonic transducers and separately controlling same, the location and direction of treatment can be selected.
Need to check novelty before this filing date? Find Prior Art

Description

Ultrasonic catheter and ultrasonic treatment device integrating mapping and ablation

[0001] This application claims priority to the Chinese patent application filed with the Patent Office of China on June 1, 2023, with application number 202310645999.4 and invention name “An ultrasonic catheter and an integrated ultrasonic therapeutic device for mapping and ablation”, the entire contents of which are incorporated by reference into this application. Technical Field

[0002] The present invention relates to the technical field of medical devices, and in particular to an ultrasonic catheter and an ultrasonic treatment device integrating mapping and ablation. Background Art

[0003] Nerve ablation is a surgical treatment that blocks nerve impulses from the body by destroying some nerve tissue. For example, current research uses catheter-based renal denervation (RDN) to treat hypertension. This procedure reduces renal and systemic sympathetic activity by destroying the renal nerve bundles and blocking the renal sympathetic nerves, thereby lowering blood pressure. The goal of RDN treatment is to ablate the sympathetic nerves surrounding the renal artery. However, because the nerves cannot be seen, the current mainstream RDN procedure is guided by vascular anatomy, lacking a clear ablation target. Furthermore, during and after treatment, it is impossible to determine whether sufficient nerve ablation has been completed to achieve the treatment goal. The immediate effect of ablation cannot be determined, and the ablation is often performed blindly.

[0004] The use of radiofrequency energy for nerve mapping has been proposed, aiming to selectively target and ablate the renal sympathetic nerves. However, several technical limitations remain. Both stimulation mapping and radiofrequency ablation require good contact between the radiofrequency electrode and the vessel wall. Current radiofrequency catheter performance limits effective mapping and ablation in some locations. Furthermore, the current field generated by the stimulation current differs from the thermal field generated by radiofrequency ablation of RDNs, resulting in a range of effects that can affect the accuracy of post-mapping ablation. Furthermore, the heat energy generated by radiofrequency ablation is generated in the vascular endothelium and surrounding tissues in contact with the electrode, ablating nerves located in the adventitia through heat conduction, making it difficult to achieve effective ablation of deeper-lying nerves. Ultrasound, a more widely studied ablation energy source after radiofrequency, has demonstrated numerous advantages. However, the use of ultrasound energy for visceral nerve stimulation and mapping has not been reported. Furthermore, current ultrasound ablation methods are mostly single-point or circumferential, lacking directional or selective targeting.

[0005] Summary of the Invention

[0006] In view of the above problems, the present invention provides an ultrasound catheter and an integrated ultrasound treatment device for mapping and ablation that overcomes or at least partially solves the above problems. The technical solutions are as follows:

[0007] An ultrasonic catheter comprises a catheter body, wherein the catheter body comprises a first end and a second end opposite to each other, wherein the first end is open and the second end can be either an open end or a closed end;

[0008] At least one group of ultrasonic generating components is provided on the tube wall of the catheter body, and a cable is provided in the hollow cavity of the catheter body. One end of the cable is connected to the ultrasonic generating component, and the other end of the cable extends from the first end of the catheter body and is connected to the cable interface; the ultrasonic generating component includes a mapping mode and an ablation mode. In the mapping mode, the ultrasonic generating component generates a first ultrasonic wave, and in the ablation mode, the ultrasonic generating component generates a second ultrasonic wave.

[0009] The above structure is optional. In the mapping mode, the first ultrasonic wave is a pulsed ultrasonic wave with a pulse frequency of 0.5Hz-5kHz, a duty cycle of 1%-80%, an ultrasonic frequency of 9mHz±50%, and an acoustic power of 0.1W-10W; in the ablation mode, the second ultrasonic wave is a continuous ultrasonic wave with an ultrasonic frequency of 9mHz±50% and an acoustic power of 0.1W-10W.

[0010] In the above structure, optionally, the ultrasonic generating element is arranged near the second end of the catheter body, and at least one group of the ultrasonic generating elements is arranged along the extension direction of the central axis of the catheter body, and each group of the ultrasonic generating elements includes at least one ultrasonic transducer arranged around the wall of the catheter body.

[0011] In the above structure, optionally, each of the ultrasonic transducers is individually controlled, so that the ultrasonic catheter can selectively transmit the first ultrasonic wave or the second ultrasonic wave to different areas and different directions.

[0012] In the above structure, optionally, the ultrasonic transducer includes a piezoelectric chip layer and a backing layer, the first surface of the piezoelectric chip layer is bonded to the backing layer, and the first ultrasonic wave or the second ultrasonic wave is emitted from the second surface of the piezoelectric chip layer opposite to the first surface; the piezoelectric chip layer is connected to the cable.

[0013] In the above structure, optionally, a balloon is provided closely to the outer side of the tube wall of the catheter body, and the ultrasonic generating element is completely wrapped by the balloon; at least one water pipe is also provided in the hollow cavity of the catheter body, one end of the water pipe passes through the tube wall of the catheter body and is connected to the balloon, and the other end of the water pipe extends from the first end of the catheter body and is connected to the water pipe interface.

[0014] In the above structure, optionally, the hollow cavity of the catheter body is equipped with two water pipes. When in use, the cooling liquid flows into the balloon from one water pipe and flows out of the balloon from the other water pipe.

[0015] In the above structure, optionally, the piezoelectric wafer layer is a planar structure or a curved structure.

[0016] In the above structure, optionally, the surface of the piezoelectric wafer layer is provided with a coating for imaging.

[0017] In the above structure, optionally, the catheter body is further connected to a rotation control device, and the rotation control device is used to control the catheter body to rotate along the central axis.

[0018] In the above structure, optionally, a guide wire is further provided in the hollow cavity of the catheter body.

[0019] An integrated ultrasonic treatment device for mapping and ablation comprises a control end and an execution end, the execution end comprising a water pump and the ultrasonic catheter as described above; the control end communicates with the ultrasonic catheter via the cable interface, and the water pipe interface connects the control end and the water pump; the control end is used to send a control signal to control the ultrasonic generating element to generate the first ultrasonic wave or the second ultrasonic wave, and is used to send a control signal to control the water pump to inject water into and / or pump water out of the balloon.

[0020] Optionally, in the above device, the first ultrasound wave is used to map visceral nerves, and the second ultrasound wave is used to ablate visceral nerves.

[0021] The above-mentioned device, optionally, the execution end also includes a physiological signal detection device, and the physiological signals detected by the physiological signal detection device include blood pressure, heart rate, muscle sympathetic nerve signals and Doppler ultrasound imaging signals; the control end communicates with the physiological signal detection device, receives the physiological signals detected by the physiological signal detection device, and switches the mapping mode and ablation mode of the ultrasonic generating element according to the detection results.

[0022] Optionally, in the above-mentioned device, before performing the ablation operation, the control end controls the ultrasonic wave generator to emit the first ultrasonic wave to the area to be treated for pre-ablation mapping; the control end also obtains the physiological signal detected by the physiological signal detection device that can reflect the pre-ablation mapping result, and determines the point in the area to be treated that needs to be ablated;

[0023] When performing an ablation operation, the control end controls the ultrasonic transducer in the ultrasonic generating element corresponding to the point to be ablated to emit the second ultrasonic wave, thereby ablating the point to be ablated.

[0024] The above-mentioned device, optionally, after each ablation operation, the control end controls the ultrasonic transducer in the ultrasonic generating part corresponding to the ablated point to emit the first ultrasonic wave for post-ablation mapping; the control end also obtains the physiological signal detected by the physiological signal detection device that can reflect the post-ablation mapping result, and determines whether there are any points in the ablated points that need to be ablated again.

[0025] The above-mentioned device optionally includes a display screen, which is used to display the physiological signal conditions detected by the physiological signal detection device acquired by the control end and the point status distribution diagram of the area to be treated. The point status distribution diagram of the area to be treated is updated by the control end according to the physiological signals detected by the physiological signal detection device after each marking.

[0026] Compared with the prior art, the present invention has the following advantages: in the ultrasound catheter provided in the embodiment of the present invention, the ultrasound generator has a mapping mode and an ablation mode, and the integration of mapping and ablation can be achieved by switching the working mode of the ultrasound generator, and the same ultrasound generator is used for mapping and ablation, which can achieve precise targeted treatment, solving the problem of lack of clear ablation targets in current nerve ablation treatment, resulting in blind ablation; the embodiment also provides a balloon to provide cooling liquid circulation, which can physically cool the blood and vascular endothelium around the catheter body, thereby protecting the blood vessels; further, multiple separately controlled ultrasound transducers can be optionally provided along the axial and circumferential directions of the catheter body, so that the ultrasound catheter of the present invention can selectively map and ablate treatment points at different positions; the embodiment of the present invention also proposes an ultrasound treatment device that integrates mapping and ablation using the above-mentioned ultrasound catheter, and the embodiment combines physiological signal detection to achieve accurate ablation control and efficacy verification.

[0027] The above description is only an overview of the technical solution of the present invention. In order to more clearly understand the technical means of the present invention, it can be implemented in accordance with the contents of the specification. In order to make the above and other purposes, features and advantages of the present invention more obvious and easy to understand, the specific implementation methods of the present invention are specifically listed below. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Various other advantages and benefits will become apparent to those skilled in the art upon reading the detailed description of the preferred embodiment below. The accompanying drawings are for illustration purposes only and are not to be considered as limiting the present invention. The same reference symbols are used throughout the drawings to represent the same components. In the drawings:

[0029] FIG1 is a schematic structural diagram of an ultrasonic catheter provided by an embodiment of the present invention;

[0030] FIG2 is another schematic structural diagram of an ultrasonic catheter provided by an embodiment of the present invention;

[0031] FIG3 is another schematic structural diagram of an ultrasonic catheter provided by an embodiment of the present invention;

[0032] FIG4 is another schematic structural diagram of an ultrasonic catheter provided by an embodiment of the present invention;

[0033] FIG5 is another schematic structural diagram of an ultrasonic catheter provided by an embodiment of the present invention;

[0034] FIG6 is another schematic structural diagram of an ultrasonic catheter provided by an embodiment of the present invention;

[0035] FIG7 is another schematic structural diagram of an ultrasonic catheter provided by an embodiment of the present invention;

[0036] FIG8 is another schematic structural diagram of an ultrasonic catheter provided by an embodiment of the present invention;

[0037] FIG9 is another schematic structural diagram of an ultrasonic catheter provided by an embodiment of the present invention;

[0038] FIG10 is another schematic structural diagram of an ultrasonic catheter provided by an embodiment of the present invention;

[0039] FIG11 is another schematic structural diagram of an ultrasonic catheter provided by an embodiment of the present invention;

[0040] FIG12 is another schematic structural diagram of an ultrasonic catheter provided by an embodiment of the present invention;

[0041] FIG13 is a schematic structural diagram of an integrated mapping and ablation ultrasound treatment device provided by an embodiment of the present invention;

[0042] Among them, 1-catheter body; 2-ultrasound generating element; 3-cable; 4-cable interface; 5-blood vessel; 6-piezoelectric chip layer; 7-backing layer; 8-handle; 9-twist control mechanism; 10-balloon; 11-water pipe; 12-water pipe interface; 13-water pump; 14-control host. DETAILED DESCRIPTION

[0043] Exemplary embodiments of the present disclosure will be described in more detail below with reference to the accompanying drawings. Although exemplary embodiments of the present disclosure are shown in the accompanying drawings, it should be understood that the present disclosure can be implemented in various forms and should not be limited by the embodiments set forth herein. Rather, these embodiments are provided to enable a more thorough understanding of the present disclosure and to fully convey the scope of the present disclosure to those skilled in the art.

[0044] Reference Figure 1 shows a structural schematic diagram of an ultrasonic catheter provided by an embodiment of the present invention. The structure shown in Figure 1 is a feasible implementation scheme of the ultrasonic catheter provided by an embodiment of the present invention. The ultrasonic catheter specifically includes a catheter body 1, and the catheter body 1 includes a first end and a second end relative to each other and a tubular structure formed between the first end and the second end. The first end is open, and the second end can be optionally a closed end, and the second end can also be optionally an open end; at least one group of ultrasonic generating parts 2 are provided on the tube wall of the catheter body 1, and a cable 3 is provided in the hollow cavity of the catheter body, one end of the cable 3 is connected to the ultrasonic generating part 2, and the other end of the cable 3 extends from the first end of the catheter body 1 and is connected to the cable interface 4; the ultrasonic generating part 2 includes a mapping mode and an ablation mode. In the mapping mode, the ultrasonic generating part 2 generates a first ultrasonic wave, and in the ablation mode, the ultrasonic generating part 2 generates a second ultrasonic wave.

[0045] In the ultrasonic catheter provided in an embodiment of the present invention, the catheter body 1 is a hollow tubular structure, with at least one of its two ends being open. The first end is open, and the second end can be open or closed. The second end is the distal end, and the first end is the proximal end. It should be noted that in this disclosure, the positional relationships such as "distal end" and "proximal end" refer to the relative positional relationship between the operator and the ultrasonic catheter, where "distal end" refers to a position away from the operator, and "proximal end" refers to a position close to the operator.

[0046] The ultrasonic generating component 2 can be optionally arranged near the second end of the catheter body 1, that is, the ultrasonic generating component 2 can be optionally arranged at a position near the distal end on the wall of the catheter body 1. The cable 3 runs through the hollow cavity of the catheter body 2. One end of the cable 3 is connected to the ultrasonic generating component 2 at the distal end, and the other end is extended from the proximal opening of the catheter body 1 and connected to the cable interface 4. The cable 3 and the cable interface 4 can provide a control channel for the ultrasonic generating component 2. The cable interface 4 can be connected to the control host, and the control host sends a control signal to the ultrasonic generating component 2 through the cable 3 to control the ultrasonic generating component 2 to emit a first ultrasonic wave for mapping nerves or a second ultrasonic wave for ablating nerves.

[0047] In the ultrasonic catheter provided by an embodiment of the present invention, by adjusting the working mode of the ultrasonic generator 2, the ultrasonic generator 2 can switch between the mapping mode and the ablation mode, thereby achieving the goal of using a single ultrasonic generator 2 to complete both mapping and ablation. Furthermore, in the mapping mode, the ultrasonic generator 2 generates a first ultrasonic wave, which can be a pulsed ultrasonic wave, with a pulse frequency of 0.5Hz-5kHz, a duty cycle of 1%-80%, and an ultrasonic frequency of 9mHz±50%, that is, the ultrasonic frequency can be selected from 9mHz-9mHz×50% to 9mHz+9mHz×50%, specifically, the ultrasonic frequency is 4.5mHz-13.5mHz, and the acoustic power is 0.1W-10W; in the ablation mode, the ultrasonic generator 2 generates a second ultrasonic wave, which can be a continuous ultrasonic wave, with an ultrasonic frequency of 9mHz±50%, and an acoustic power of 0.1W-10W. In some embodiments, in the mapping mode, a pulsed ultrasonic wave with a pulse frequency of 2 Hz, a duty cycle of 20%-30%, an ultrasonic frequency of 9.6 mHz, an electric power of approximately 12 W, and an acoustic power of approximately 900 mW is set as the first ultrasonic wave; in the ablation mode, a continuous ultrasonic wave with an ultrasonic frequency of 9.6 mHz, an electric power of approximately 12 W, and an acoustic power of approximately 900 mW is set as the second ultrasonic wave.

[0048] The ultrasound catheter provided in the embodiment of the present invention can optionally use ultrasonic energy to stimulate and ablate visceral nerves, such as the renal sympathetic nerves. Generally speaking, ultrasonic stimulation is mostly used to stimulate the central nervous system and peripheral nerves, and ultrasonic ablation is not involved in the research of the central nervous system and peripheral nerves. The ultrasound catheter provided in the embodiment of the present invention can not only stimulate the visceral nerves, but also combine ultrasonic stimulation and ultrasonic ablation to solve the problem of blind ablation due to the lack of clear ablation targets during the treatment of visceral nerves. For example, in the catheter renal sympathetic ablation treatment, referring to FIG2 , a schematic diagram of the ultrasound catheter provided in the embodiment of the present invention in the blood vessel during treatment is given. The distal end of the catheter body 1 of the ultrasound catheter provided in the embodiment of the present invention is extended into the blood vessel 5 of the renal artery, and the ultrasonic generating part 2 arranged near the distal end of the catheter body 1 emits the first ultrasonic wave or the second ultrasonic wave to the renal nerve area in the human renal artery for mapping or ablating the renal nerves.

[0049] The ultrasonic catheter provided by an embodiment of the present invention can optionally include at least one group of ultrasonic generators disposed along the central axis of the catheter body 1, each group of ultrasonic generators comprising at least one ultrasonic transducer disposed around the wall of the catheter body. Multiple groups of ultrasonic generators 2 are disposed along the central axis of the catheter body 1, enabling the ultrasonic waves emitted by the ultrasonic catheter provided by the embodiment of the present invention to cover treatment areas at different locations. Each group of ultrasonic generators 2 can be controlled uniformly, divided into different subgroups, or individually controlled. When controlled in different subgroups, for example, four groups of ultrasonic generators can be divided into two subgroups, each including two groups of ultrasonic generators. The two groups of ultrasonic generators within the same subgroup are separated by a predetermined distance, which can be set based on clinical practice. The two groups of ultrasonic generators within the same subgroup can be connected using a flexible material, such as silicone rubber, to provide the ultrasonic catheter provided by the embodiment of the present invention with bendability and flexibility, ensuring flexibility within the body. When each group of ultrasonic generating components 2 is controlled individually, each group of ultrasonic generating components 2 can be connected to the corresponding cable 3 respectively and controlled individually by the corresponding cable 3, so as to enable the ultrasonic generating components 2 set at different positions according to actual needs, thereby ensuring a wide treatment range, improving treatment efficiency, and providing targeted treatment.

[0050] In the ultrasonic catheter provided in an embodiment of the present invention, each group of the ultrasonic generating components includes at least one ultrasonic transducer arranged around the wall of the catheter body. Figures 3 and 4 respectively show the structural schematic diagrams of the ultrasonic generating components including one ultrasonic transducer and two ultrasonic transducers.

[0051] When only one ultrasonic transducer is provided in a group of ultrasonic generating elements, as shown in FIG3 , an opening is provided on the wall of the catheter body 1, and the ultrasonic transducer can be optionally welded to the opening. Furthermore, the ultrasonic transducer includes a piezoelectric wafer layer 6 and a backing layer 7, wherein a first surface of the piezoelectric wafer layer 6 is bonded to the backing layer 7, and the first ultrasonic wave or the second ultrasonic wave is emitted from a second surface of the piezoelectric wafer layer 6 opposite to the first surface; the piezoelectric wafer layer is connected to the cable 3. At least a portion of the piezoelectric wafer layer 6 and the backing layer 7 are disposed within the hollow cavity of the catheter body 1, with the first surface of the piezoelectric wafer layer 6 facing the interior of the catheter body 1, and the second surface of the piezoelectric wafer layer 6 passes through the catheter body 1 to emit the first ultrasonic wave or the second ultrasonic wave outward.

[0052] Furthermore, the ultrasonic transducer can be optionally positioned parallel to the central axis of the catheter body 1, emitting an ultrasonic beam perpendicular to the direction in which the central axis of the catheter body 1 extends. However, it is worth noting that the embodiments of the present invention do not limit the direction in which the ultrasonic transducer emits the ultrasonic beam; in addition to emitting an ultrasonic beam perpendicular to the direction in which the central axis of the catheter body 1 extends, ultrasonic beams in other directions can also be emitted. The cable interface 4 can optionally serve as a transducer interface, which provides energy to the ultrasonic transducer via an external control host.

[0053] When more than one ultrasonic transducer is provided in a set of ultrasonic generating elements, the ultrasonic transducers can be evenly spaced along the circumference of the catheter body wall or at random intervals. As shown in FIG4 , two ultrasonic transducers are provided along the circumference of the catheter body wall. FIG5 also shows a cross-sectional view of the structure shown in FIG4 . Two openings are provided along the circumference of the catheter body wall. The first surfaces of the two ultrasonic transducers face the interior of the catheter body 1, while the second surfaces extend through the two openings in the catheter body wall, emitting ultrasonic beams in different directions outward from the catheter body 1.

[0054] Because interventional ultrasound catheters operate in pulsed mode, the radiated acoustic pressure they generate can create a reaction force on the catheter. This reaction force can cause the catheter to shift within the blood vessel, thereby affecting the accuracy of treatment. If two ultrasonic transducers are symmetrically positioned on the catheter body, and the two ultrasonic beams emitted by the two transducers have the same energy but are emitted in opposite directions (e.g., both ultrasonic beams are emitted radially along the catheter body), the reaction forces generated by the two ultrasonic beams on the catheter can offset each other, thereby improving the catheter's stability within the blood vessel. Furthermore, by placing multiple ultrasonic transducers around the catheter body, multiple targets can be ablated simultaneously, improving the efficiency of RDN treatment.

[0055] Referring to Figures 6 and 7 , schematic diagrams of the ultrasonic wave generator structure include three and four ultrasonic transducers disposed around the perimeter of the catheter body, respectively. Furthermore, a greater number of ultrasonic transducers can be disposed around the perimeter of the catheter body, enabling the emission of the first or second ultrasonic wave in any direction along the perimeter of the catheter body. Taking the structure of Figure 7 as an example, four ultrasonic transducers are disposed around the perimeter of the catheter body, each acting on four quadrants within the blood vessel, enabling multi-directional, multi-quadrant mapping and ablation within the vessel.

[0056] Taking four-quadrant treatment as an example, under the guidance of X-ray imaging, the ultrasonic transducer portion of the ultrasound catheter is inserted into one renal artery (e.g., the left side) through femoral artery puncture. The control host inputs commands, sending an electrical drive signal to the ultrasonic transducer in quadrant I in mapping mode to generate a first ultrasonic wave for mapping, stimulating the renal nerve tissue in the intravascular region of quadrant I. If the patient experiences elevated blood pressure, heart rate, or sympathetic hyperactivity, the ablation mode is used to generate a second ultrasonic wave for ablation. After the treatment is completed, the mapping mode is used again to verify the efficacy. If the patient experiences elevated blood pressure, heart rate, or sympathetic hyperactivity, indicating poor treatment effectiveness, an additional ablation treatment is performed. If the patient does not experience these symptoms, the quadrant region is successfully treated. After successful treatment, the control host continues to input operating commands to the ultrasonic transducers in quadrants II, III, and IV in sequence, treating the intravascular regions of quadrants II, III, and IV.

[0057] If only one ultrasonic transducer is disposed around the perimeter of the catheter body, or if a relatively small number of ultrasonic transducers are disposed, such that coverage is not possible in any direction around the perimeter of the catheter body, a rotation control device can be added, as shown in FIG1 , to control the rotation of the catheter body 1 along its central axis, thereby changing the direction of the ultrasonic beam emitted by the ultrasonic transducer so that coverage is achieved in all directions around the perimeter of the catheter body. Referring to FIG1 , a handle 8 is disposed at the proximal end of the catheter body 1 , and a torque control mechanism 9 is disposed on the handle 8 . By controlling the torque control mechanism 9 of the handle 8 , the catheter body 1 is axially rotated around its central axis, thereby driving the ultrasonic transducer disposed on the catheter body 1 to perform multi-directional intravascular ablation with controllable angles.

[0058] Optionally, referring to Figure 1, the rotation control device includes a handle 8 and a twist control mechanism 9 arranged on the handle 8. The handle 8 is connected to the first end of the catheter body 1. The handle 8 can be optionally a tubular structure with a hollow cavity. The cable 3 and other structures passing through the catheter body 1 enter from the opening at one end of the handle 8, and then leave from the opening at the other end of the handle 8 and connect to the cable interface 4. When in use, the operator can hold the handle 8 to drive the catheter body 1 to move, and further control the rotation of the catheter body 1 through the twist control mechanism 9 on the handle 8.

[0059] In the ultrasonic catheter provided by the embodiments of the present invention, the piezoelectric wafer layer of the ultrasonic transducer can adopt a planar or curved structure. Figures 3-7 illustrate the case of an ultrasonic transducer employing a planar piezoelectric wafer layer. The ultrasonic waves generated by a planar wafer-type ultrasonic transducer have excellent selectivity and directionality. During treatments such as renal sympathectomy, the ultrasound waves can pass through the vascular intima and media to reach the renal artery adventitia and surrounding fat. Furthermore, by adjusting the operating mode of the ultrasonic transducer, the transducer can emit pulsed or continuous ultrasound waves, enabling mapping and ablation modes, thereby stimulating or destroying the renal sympathetic nerves.

[0060] Due to the structural characteristics of the planar chip-type ultrasonic transducer, the non-focused sound beam released by the planar chip-type ultrasonic transducer may have dead angles or blind spots for stimulation and ablation. In order to stimulate and ablate the target area in the blood vessel without blind spots and make the treatment range coverage more comprehensive, optionally, in the ultrasonic catheter provided by the embodiment of the present invention, the piezoelectric chip layer of the ultrasonic transducer can also be set to a curved surface structure, and the curved surface structure of the piezoelectric chip layer can be selected as a circular arc surface, a quadratic curve surface, or other curved surfaces. The curved chip-type ultrasonic transducer can perform subcircular mapping or ablation of the peripheral nerve tissue in the kidney, and there are no dead angles or blind spots for stimulation and ablation.

[0061] The ultrasonic catheter provided in an embodiment of the present invention can also be equipped with one or more ultrasonic transducers using a curved surface structured piezoelectric chip layer along the wall of the catheter body. Reference Figure 8 shows a structural schematic diagram of an ultrasonic catheter in which four ultrasonic transducers using a curved surface structured piezoelectric chip layer are arranged along the wall of the catheter body. Figure 9 is a cross-sectional view of Figure 8 , in which the four ultrasonic transducers using a curved surface structured piezoelectric chip layer respectively emit ultrasonic beams in four directions.

[0062] Arranging multiple ultrasonic transducers along the perimeter of the catheter body 1 enables the emission of ultrasonic beams in multiple directions without rotating the catheter body, achieving multi-quadrant intravascular treatment and simplifying operation. When more than one ultrasonic transducer is arranged along the perimeter of the catheter body 1, each ultrasonic transducer can be controlled collectively or individually. A control host connects the ultrasonic transducers via cable 3 and controls each to operate in mapping or ablation mode, thereby treating visceral nerves.

[0063] The ultrasonic transducer's backing layer 7 is tightly fitted to the piezoelectric wafer layer 6. The backing layer 7 can be a rectangular frame structure made of metal (such as copper or stainless steel), polyester resin, or other materials with excellent thermal conductivity and sound absorption. The backing layer 7 supports the piezoelectric wafer layer 6 and reflects ultrasonic energy propagating toward the first surface of the wafer. This increases the ultrasonic power on the reflecting surface while reducing interference from opposing ultrasonic waves, absorbing unwanted sound waves from the first surface of the piezoelectric wafer layer 6. The thickness of the backing layer 7 can be set according to the ultrasonic wavelength. Furthermore, the backing layer 7 dissipates heat from the operating ultrasonic transducer, preventing heat from damaging other structures within the ultrasonic catheter.

[0064] In the ultrasonic catheter provided by an embodiment of the present invention, optionally, referring to Figure 1 and Figure 10, which show an enlarged structural view of the distal end of the catheter body 1 of the ultrasonic catheter, a balloon 10 may be tightly provided on the outer side of the tube wall of the catheter body 1, and the ultrasonic generating part 2 is completely wrapped by the balloon 10; at least one water pipe 11 is also provided in the hollow cavity of the catheter body 1, and one end of the water pipe 11 passes through the tube wall of the catheter body 1 and is connected to the balloon 10, and the other end of the water pipe 11 extends from the opening at the first end of the catheter body 1 and is connected to the water pipe interface 12.

[0065] The balloon 10 covers the outside of the catheter body 1 and encloses the ultrasonic generator 2, preventing the ultrasonic generator 2 from directly contacting intravascular substances when the ultrasonic catheter is in use. At the same time, the side of the balloon 10 that contacts the outside of the catheter body 1 is open and connected to one end of a water pipe 11. The water pipe 11 runs within the hollow cavity of the catheter body 1 and extends from the opening at the first end of the catheter body 1. It can also optionally pass through the hollow cavity of the handle 8 and connect to an external water pipe interface 12. Coolant can be optionally introduced into the balloon 10, and the balloon 10 is connected to the outside world through the water pipe 11. The water pipe interface 12 provided on the water pipe 11 can be optionally connected to a water pump, which can be used to inject or discharge coolant into or out of the balloon to achieve circulation of the coolant within the balloon.

[0066] Furthermore, the hollow cavity of the catheter body 1 is built with two water pipes 11, one for water inlet and one for water outlet. One end of each water pipe 11 is connected to the balloon 10, and the other end is connected to a water pipe interface 12. Reference Figure 11 shows a schematic diagram of cooling liquid being injected into the balloon 10 through the water pipes 11. When the balloon 10 is not filled with water, there is no gas or liquid inside. The balloon 10 is tightly attached to the outer surface of the catheter body 1 and covers the ultrasonic generator 2, isolating the ultrasonic generator 2 from the blood. During use, an external water pump can be used to flow cooling liquid from one water pipe into the balloon 10, and the cooling liquid in the balloon 10 flows out of the balloon 10 through the other water pipe. As shown in Figure 11, this ensures continuous circulation of cooling liquid within the balloon 10 during treatment. This integrated water circulation system can effectively reduce the temperature of the blood and surrounding blood vessels during treatment, better protecting the blood vessels. It can also physically cool the vascular endothelium around the catheter, thereby protecting the vascular endothelium and reducing the occurrence of surgical complications.

[0067] When multiple groups of ultrasonic generating components are arranged along the extension direction of the central axis of the catheter body, each group of ultrasonic generating components can be provided with an independent balloon 10, and each ultrasonic transducer in the ultrasonic generating component can also be connected to an independent cable 3 to achieve individual or group control.

[0068] In the ultrasound catheter provided by an embodiment of the present invention, a balloon 10 and an ultrasonic generator 2, disposed at the distal end of the catheter body 1, are connected to the outside world via a water pipe 11 and a cable 3, respectively. The water pipe 11 and cable 3 are installed within the hollow cavity of the catheter body 1. One end of the water pipe 11 and cable 3 is connected to the balloon 10 and ultrasonic generator 2 at the distal end of the catheter body 1, and the other end extends from the proximal end of the catheter body 1. FIG. 12 shows a cross-sectional schematic diagram of the catheter body 1. In addition to serving as a channel for installing the water pipe 11 and cable 3, the hollow cavity of the catheter body 1 can also optionally serve as a channel for a guidewire 12. The guidewire 12 that can pass through the hollow cavity of the catheter body 1 includes, but is not limited to, a coronary guidewire and a microguidewire. The function of the catheter body 1 is to provide support for the entire ultrasound catheter, facilitating delivery of the ultrasonic transducer used for mapping and ablation to the treatment site within the human vascular cavity. The diameter of the catheter body can be selected from a variety of options based on clinical needs. The water pipe 11 passing through the hollow cavity of the catheter body 1 can also cool the structures within the hollow cavity of the catheter body 1.

[0069] In the ultrasonic catheter provided in an embodiment of the present invention, the surface of the ultrasonic generator 2 may optionally be provided with a visible coating, such as a coating visible under X-ray imaging, such as gold or platinum. The coating may optionally be provided on the surface of the piezoelectric crystal layer of the ultrasonic transducer. This allows the operator to determine, under X-ray imaging, whether the therapeutic ultrasonic transducer has reached the target treatment area within the blood vessel before controlling the ultrasonic generator 2 to emit ultrasonic waves.

[0070] An embodiment of the present invention also proposes an ultrasonic treatment device that uses the above-mentioned ultrasonic catheter and can integrate mapping and ablation. The structural diagram of the ultrasonic treatment device can be referred to Figure 13. The ultrasonic treatment device includes: a control end and an execution end, and the execution end includes a water pump 13 and an ultrasonic catheter as in the above-mentioned embodiment; the control end communicates with the ultrasonic catheter through the cable interface and the cable 3, and the water pipe 11 is connected to the water pump 13 through the water pipe interface; the control end is used to send a control signal to control the ultrasonic generating part 2 to generate the first ultrasonic wave or the second ultrasonic wave, and is used to send a control signal to control the water pump 13 to inject water and / or pump water into the balloon 10.

[0071] The ultrasonic therapeutic device proposed in an embodiment of the present invention can receive operator control commands through a control terminal and, based on the operator's control commands, input ultrasonic control signals to the ultrasonic transducer. These signals include electrical signals that control parameters such as the amplitude, frequency, and phase of the ultrasonic waves, thereby controlling parameters such as the frequency, operating mode, and energy level of the emitted ultrasonic waves. Furthermore, the device can optionally monitor the operating status of the ultrasonic transducer in real time. The control terminal can be a control host 14, which includes a processor, a display screen, control buttons, and other components.

[0072] Furthermore, in the ultrasound treatment device proposed in the embodiment of the present invention, the execution end may also optionally include a physiological signal detection device, and the physiological signal detection device may optionally include an arterial catheter pressure sensor and flow sensor, a blood pressure detection device, a muscle sympathetic electrophysiological sensor, a Doppler ultrasound imager, an electrocardiogram monitor and other devices for detecting physiological signals including blood pressure, heart rate, muscle sympathetic nerve signals and Doppler ultrasound imaging signals; the control end communicates with the physiological signal detection device, receives the physiological signals detected by the physiological signal detection device, and switches the mapping mode and ablation mode of the ultrasound generator according to the detection results. For example, when performing transcatheter renal sympathetic ablation, the mechanical effect of the first ultrasound wave can be used to stimulate the renal nerves in the renal artery in the mapping mode, and the treatment target can be accurately located in combination with feedback information such as changes in blood pressure, heart rate, and muscle sympathetic excitability of the treatment subject. In the ablation mode, the thermal effect and cavitation effect of the second ultrasound wave can be used to destroy the renal sympathetic nerve target tissue in the renal artery.

[0073] During treatment, the control terminal, such as the control host, can display real-time blood pressure, real-time muscle sympathetic nerve signals, heart rate variability, renal artery Doppler ultrasound images and parameters on a display screen. During ultrasound stimulation mapping and after ablation to verify the efficacy, the control host can make judgments based on changes in the detected physiological signals. That is, the control host can automatically judge the results based on the changes in the detected physiological signals. If there are signs of increased blood pressure, increased heart rate, or sympathetic nerve excitation, it means that the ablation or mapping area is a "hot spot" (or a positive stimulation point). The control terminal can also mark the distribution of positive stimulation points on a preset pattern diagram based on the multi-point judgment results, and generate a point status distribution map of the area to be treated to intuitively display the distribution of positive sites. If there are no signs of increased blood pressure, increased heart rate, or sympathetic nerve excitation, or if there is a significant decrease in blood pressure, it means that the ablation or mapping area is a "cold spot." During treatment, it is necessary to accurately find the "hot spot" for ablation, while retaining the "cold spot." After the control terminal uses physiological signal detection equipment to identify hot and cold spots, it generates different control signals based on the identification results, controlling the ultrasonic generator to switch between mapping mode and ablation mode, and further controlling the coolant flowing through the balloon. After calibrating the distribution of positive sites, the control host can generate treatment recommendations based on the distribution of positive sites in the point state distribution map of the treatment area according to preset values. After the treatment and ablation are completed, the point state distribution map of the treatment area can be verified point by point or verified instantly for single point ablation. The point state distribution map of the treatment area is updated to display the effect and residual state distribution after the ablation is completed.

[0074] Before performing an ablation operation using the ultrasonic treatment device proposed in an embodiment of the present invention, the control end first controls the ultrasonic generator to emit the first ultrasonic wave to the area to be treated for pre-ablation mapping; optionally, when the ultrasonic generator includes multiple ultrasonic transducers arranged in the axial and circumferential directions of the ultrasonic catheter, only the ultrasonic transducer corresponding to the area to be treated can be enabled to emit the first ultrasonic wave for mapping, and then the control end obtains the physiological signal that can reflect the pre-ablation mapping result detected by the physiological signal detection device, and determines the point in the area to be treated that needs to be ablated based on the detection result; optionally, a point status distribution diagram of the area to be treated corresponding to this time is displayed on the display screen, and each point in the point status distribution diagram of the area to be treated can be optionally marked as a hot spot or a cold spot. When performing an ablation operation, the control end controls the ultrasonic transducer in the ultrasonic generator corresponding to the point to be ablated determined according to the pre-ablation mapping to emit the second ultrasonic wave to ablate the point to be ablated.

[0075] Furthermore, mapping can not only be performed before ablation to determine the ablation point; it can also be performed again after each ablation to determine the effect of ablation and determine whether additional ablation is needed. Optionally, after each ablation operation, the control end controls the ultrasonic transducer corresponding to the ablated point in the ultrasonic generating part to emit the first ultrasonic wave for post-ablation mapping; then the control end obtains the physiological signal detected by the physiological signal detection device that can reflect the post-ablation mapping result, updates the point status distribution map of the area to be treated on the display screen, and determines whether there are points in the ablated points that need to be ablated again. If there are, the ultrasonic transducer corresponding to the point that needs to be ablated again is controlled to emit the second ultrasonic wave for re-ablation, and the effect after re-ablation is determined; if not, the ultrasonic ablation treatment of the area to be treated is completed.

[0076] The ultrasound therapy device proposed in an embodiment of the present invention can be used to emit ultrasound waves for mapping or ablating visceral nerves. By utilizing the properties of ultrasound that can propagate in solid tissues and the sensitivity of nerves to ultrasound energy, ultrasound energy is used to map and ablate visceral nerves. The following is an example of using the ultrasound therapy device provided in an embodiment of the present invention for renal sympathetic desensitization (RDN) treatment.

[0077] Before ultrasound treatment, connect the cable interface of the ultrasound catheter to the control host, and connect the water pipe connector to the water pump; under the guidance of X-ray imaging, insert the ultrasonic transducer part (optionally also including a balloon) provided on the ultrasound catheter provided by the embodiment of the present invention into one side of the renal artery (such as the left side) through femoral artery puncture; input instructions through the control host to start the water pump to inject water into the balloon, and after confirming that the water path is running stably, start the mapping mode of the ultrasonic generating component through the control host; first send an electric drive signal to the ultrasonic transducer in the mapping mode. In the mapping mode, the working mode of the ultrasonic transducer is the pulse mode. The pulse frequency can be set to 2Hz, the duty cycle is 20%-30%, the ultrasonic frequency is 9.6mHz, the electric power is about 12w, the sound power is about 900mW, and the stimulation time is about 10s. The ultrasound transducer generates a first ultrasonic wave for mapping to stimulate the renal nerves in the renal artery for 10s. If the subject shows sympathetic excitement such as increased blood pressure and heart rate, and sympathetic nerve activity, the mapping point is a "hot spot" and the system switches to ablation mode. In ablation mode, the ultrasound transducer works in continuous mode. The ultrasound frequency can be set to 9.6mHz, the electric power is about 12w, the acoustic power is about 900mW, and the ablation time is 30s. The second ultrasonic wave for ablation is generated for treatment. After the treatment, the mapping mode is used again to verify the efficacy. If the subject shows symptoms such as increased blood pressure, heart rate, and sympathetic nerve excitement, indicating that the treatment effect is poor, an additional ablation treatment is performed. If the subject does not show the above symptoms, the treatment is successful.

[0078] Through the above method, the target tissue is further identified based on changes in the patient's physiological signals (this step can be determined by the operator or automatically determined and a treatment recommendation map generated by the control unit). The system switches to ablation mode for positive stimulation points and performs ablation. After treatment, the system switches to mapping mode to verify the efficacy of the treatment point. If a sympathetic response persists, compensatory ablation therapy is administered. If the treatment is successful or the stimulation point is negative, the pump is activated to pump out the coolant within the balloon, causing it to deflate. The ultrasound catheter handle is then used to adjust the position or direction of the ultrasound transducer at the distal end of the ultrasound catheter to treat the next site. Alternatively, if each ultrasound transducer is controlled independently, the control unit can select the ultrasound transducer at the corresponding location to treat the next site. When treating the next site, the above steps are repeated for the next site or the opposite renal artery. After the procedure, the control unit can optionally automatically generate an effect and residual state distribution map, reactivate the pump to deflate the balloon, and then slowly withdraw the catheter from the blood vessel to terminate the treatment.

[0079] If a group of ultrasonic generators only includes one ultrasonic transducer arranged along the wall of the catheter body, a rotation control device is added. When the treatment is successful or the mapping point is a "cold spot", the catheter body can be rotated by the twist control mechanism provided on the control handle, or the position of the ultrasonic transducer on the ultrasonic catheter in the renal blood vessel can be adjusted by the handle, such as adjusting the ultrasonic transducer to the distal, middle, or proximal part of the renal blood vessel, or the opening of the renal artery, to proceed to the next site for treatment. If multiple groups of ultrasonic generators are arranged along the central axis of the catheter body, or if a group of ultrasonic generators includes multiple ultrasonic transducers arranged along the wall of the catheter body, each ultrasonic transducer can be controlled in groups or individually, and any ultrasonic transducer can be controlled to operate in mapping mode or ablation mode, and each site can be treated in a region without rotating the catheter body, thereby reducing the difficulty of operation and the risk of treatment failure due to improper operation.

[0080] The above are merely embodiments of the present application and are not intended to limit the present application. For those skilled in the art, the present application may have various changes and variations. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present application should all be included within the scope of the claims of the present application.

Claims

1. An ultrasonic catheter, It is characterized in that A catheter body is included, the catheter body including a first end and a second end opposite to each other, the first end being open; At least one group of ultrasonic generating components is arranged on the tube wall of the catheter body, and a cable is arranged in the hollow cavity of the catheter body. One end of the cable is connected to the ultrasonic generating component, and the other end of the cable extends from the first end of the catheter body and is connected to the cable interface; the ultrasonic generating component includes a mapping mode and an ablation mode. In the mapping mode, the ultrasonic generating component generates a first ultrasonic wave, and in the ablation mode, the ultrasonic generating component generates a second ultrasonic wave.

2. The ultrasonic catheter according to claim 1, It is characterized in that In the mapping mode, the first ultrasonic wave is a pulsed ultrasonic wave with a pulse frequency of 0.5Hz-5kHz, a duty cycle of 1%-80%, an ultrasonic frequency of 9mHz±50%, and an acoustic power of 0.1W-10W; in the ablation mode, the second ultrasonic wave is a continuous ultrasonic wave with an ultrasonic frequency of 9mHz±50%, and an acoustic power of 0.1W-10W.

3. The ultrasonic catheter according to claim 1 or 2, It is characterized in that The ultrasonic generating element is arranged near the second end of the catheter body, and at least one group of the ultrasonic generating elements is arranged along the extension direction of the central axis of the catheter body. Each group of the ultrasonic generating elements includes at least one ultrasonic transducer arranged around the wall of the catheter body.

4. The ultrasonic catheter according to claim 3, It is characterized in that Each of the ultrasonic transducers is controlled individually, so that the ultrasonic catheter can selectively transmit the first ultrasonic wave or the second ultrasonic wave to different areas and different directions.

5. The ultrasonic catheter according to claim 3, It is characterized in that The ultrasonic transducer includes a piezoelectric chip layer and a backing layer. The first surface of the piezoelectric chip layer is bonded to the backing layer. The first ultrasonic wave or the second ultrasonic wave is emitted from the second surface of the piezoelectric chip layer opposite to the first surface. The piezoelectric chip layer is connected to the cable.

6. The ultrasonic catheter according to claim 1 or 2, It is characterized in that A balloon is tightly arranged on the outer side of the tube wall of the catheter body, and the ultrasonic generating element is completely wrapped by the balloon; at least one water pipe is also arranged in the hollow cavity of the catheter body, one end of the water pipe passes through the tube wall of the catheter body and is connected to the balloon, and the other end of the water pipe extends from the first end of the catheter body and is connected to the water pipe interface; a guide wire is also arranged in the hollow cavity of the catheter body.

7. The ultrasonic catheter according to claim 5, It is characterized in that The piezoelectric wafer layer is a planar structure or a curved structure.

8. The ultrasonic catheter according to claim 5, It is characterized in that The surface of the piezoelectric wafer layer is provided with a coating film for developing images.

9. The ultrasonic catheter according to claim 1 or 2, It is characterized in that The catheter body is also connected to a rotation control device, and the rotation control device is used to control the catheter body to rotate along the central axis direction.

10. An ultrasonic treatment device integrating mapping and ablation, It is characterized in that It comprises a control end and an execution end, the execution end comprises a water pump and the ultrasonic catheter as described in any one of claims 1 to 9; the control end communicates with the ultrasonic catheter via the cable interface, and the water pipe interface connects the control end and the water pump; the control end is used to send a control signal to control the ultrasonic generating element to generate the first ultrasonic wave or the second ultrasonic wave, and is used to send a control signal to control the water pump to inject water into and / or pump water out of the balloon.

11. The integrated mapping and ablation ultrasound treatment device according to claim 10, It is characterized in that The first ultrasonic wave is used for mapping visceral nerves, and the second ultrasonic wave is used for ablating visceral nerves.

12. The integrated mapping and ablation ultrasound treatment device according to claim 10 or 11, It is characterized in that The execution end also includes a physiological signal detection device, and the physiological signals detected by the physiological signal detection device include blood pressure, heart rate, muscle sympathetic nerve signals and Doppler ultrasound image signals; the control end communicates with the physiological signal detection device, receives the physiological signals detected by the physiological signal detection device, and switches the mapping mode and ablation mode of the ultrasound generator according to the detection results.

13. The integrated mapping and ablation ultrasound treatment device according to claim 12, It is characterized in that Before performing the ablation operation, the control end controls the ultrasonic wave generator to emit the first ultrasonic wave to the area to be treated for pre-ablation mapping; the control end also obtains the physiological signal detected by the physiological signal detection device that can reflect the pre-ablation mapping result, and determines the point in the area to be treated that needs to be ablated; When performing an ablation operation, the control end controls the ultrasonic transducer in the ultrasonic generating element corresponding to the point to be ablated to emit the second ultrasonic wave, so as to ablate the point to be ablated.

14. The integrated mapping and ablation ultrasound treatment device according to claim 13, It is characterized in that After each ablation operation, the control end controls the ultrasonic transducer in the ultrasonic generating element corresponding to the ablated point to emit the first ultrasonic wave for post-ablation mapping; the control end also obtains the physiological signal detected by the physiological signal detection device that can reflect the post-ablation mapping result, and determines whether there are any points among the ablated points that need to be ablated again.

15. The integrated mapping and ablation ultrasound treatment device according to claim 14, It is characterized in that The control end includes a display screen, which is used to display the physiological signal conditions detected by the physiological signal detection device and the point status distribution map of the area to be treated acquired by the control end. The point status distribution map of the area to be treated is updated by the control end according to the physiological signals detected by the physiological signal detection device after each mapping.

Citation Information

Patent Citations

  • Apparatus for mapping and ablating renal nerve distributed on renal artery

    CN103271766A

  • Device for ultrasonic stimulation of neural tissue

    CN104826243A

  • Ultrasonic diagnosis and treatment method and system

    CN106063712A

  • Multi-frequency mapping catheter and method of mapping

    CN112568988A

  • Closed-loop ultrasonic nerve regulation system and method

    CN112774048A